M Favrot - Concepedia

Author

M Favrot

Also Known As

Favrot, M. C., M C Favrot, M Favrot, M. C. FAVROT, M. C. Favrot, M. Favrot, M.-C. Favrot, M.C Favrot, M.C. Favrot, MC Favrot

116

Publications

6.6K

Citations

H-Index

Concepts

All Affiliations

Centre Léon Bérard Hôpital Edouard Herriot Inserm Institut Curie Centre international de recherche sur le cancer

About

M Favrot is an author at Centre Léon Bérard specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	33	2.1K
2	Health Sciences	7	7	224
3	Biomedical Engineering	2	2	70
4	Biochemistry	1	1	20
5	Blood Transplantation	1	1	24

M Favrot

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. G M Brodeur, Robert C. Seeger, A Barrett, Journal of Clinical Oncology Uniform CriteriaSurgical OncologyPediatric Brain TumorsGliomaPediatric Neurosurgery	1988	604
Inhibition of the Differentiation of Dendritic Cells From CD34+ Progenitors by Tumor Cells: Role of Interleukin-6 and Macrophage Colony-Stimulating Factor Christine Ménétrier‐Caux, Gilles Montmain, C Bain, Blood	1998	569
Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. Brodeur Gm, Jon Pritchard, Frank Berthold, PubMed Neuro-oncologyInternational CriteriaInterdisciplinary NeurosurgeryNeuroblastsSurgery	1994	392
Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. Isabelle Puisieux, Jos Even, Christophe Pannetier, The Journal of Immunology	1994	230
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique. H Rubie, Olivier Hartmann, Jean Michon, Journal of Clinical Oncology	1997	184
Inhibition of the Differentiation of Dendritic Cells From CD34+ Progenitors by Tumor Cells: Role of Interleukin-6 and Macrophage Colony-Stimulating Factor Christine Ménétrier‐Caux, Gilles Montmain, C Bain, Blood	1998	127
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lackingMYCN amplification Dominique Plantaz, Jo Vandesompele, Nadine Van Roy, International Journal of Cancer	2001	123
An immunohistological approach to persistent lymphadenopathy and its relevance to AIDS. George Janossy, A J Pinching, M Bofill, PubMed Primary ImmunodeficiencyAutoimmune DiseaseMedicineHuman RetrovirusImmunology	1985	105
Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas. Valérie Combaret, Christine Lasset, Didier Frappaz, Journal of Clinical Oncology	1996	89
Correlation between clinical response to interleukin 2 therapy and sustained production of tumor necrosis factor. Jean‐Yves Blay, M Favrot, Sylvie Négrier, PubMed ImmunologyRenal InflammationPathologyCell DeathImmune System	1990	88

Page 1